By Josh White
Date: Friday 05 Dec 2025
(Sharecast News) - Genedrive reported a doubling of revenue and other income to £1m for the year ended 30 June on Friday, from £0.5m a year earlier, as the point-of-care pharmacogenetic testing company shifted from a pre-commercial to a commercial focus.
By Michele Maatouk
Date: Friday 31 Oct 2025
(Sharecast News) - AIM-listed Genedrive said on Friday that shareholder David Nugent had shown "willingness" to make a cash injection into the point-of-care pharmacogenetic testing company.
By Iain Gilbert
Date: Tuesday 28 Oct 2025
(Sharecast News) - Pharmacogenetic testing business Genedrive said on Tuesday that its exclusive distribution partner in the Kingdom of Saudi Arabia, iDeal iDea for Medical Equipment Technology, has signed a memorandum of understanding with the Saudi Arabian Ministry of Health.
| Currency | UK Pounds |
| Share Price | 0.90p |
| Change Today | -0.100p |
| % Change | -10.00 % |
| 52 Week High | 2.50p |
| 52 Week Low | 0.23p |
| Volume | 14,581,693 |
| Shares Issued | 1,029.60m |
| Market Cap | £9.27m |
| RiskGrade | 747 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:29 | 318,633 @ 0.94p |
| 16:27 | 475,848 @ 0.87p |
| 16:22 | 15,639 @ 0.94p |
| 16:19 | 134,211 @ 0.87p |
| 16:15 | 26,000 @ 0.94p |
You are here: research